期刊文献+

延续性护理对乳腺癌晚期患者生存期及生活质量的影响 被引量:12

Effect of continuing nursing on survival and quality of life in patients with advanced breast cancer
下载PDF
导出
摘要 目的探讨延续性护理对乳腺癌晚期患者生存期及生活质量的影响。方法选取我院2016年6月至2017年6月收治的80例乳腺癌晚期患者为研究对象,随机将其等分为研究组和对照组,对照组给予常规护理,研究组实施延续性护理。比较两组患者生存率及生活质量。结果研究组患者1年生存率及生活质量评分均明显高于对照组(P <0.05)。结论延续性护理可有效提高患者生活质量,延长患者生存期,值得临床推广应用。 Objective To investigate the effect of continuing nursing on survival and quality of life in patients with advanced breast cancer.Methods To compare the survival rate and quality of life,80 cases of patients with advanced breast cancer treated in our hospital from June 2016 to June 2017 were observed,and randomly divided into study group and control group with equal members.Results The survival rate and quality of life scores within 1 year in the study group were significantly higher than those in the control group(P<0.05).Conclusion The application of continuing nursing could effectively improve the quality of life of patients and prolong their survival,which was worthy of clinical promotion and application.
作者 徐研文 方晓玲 XU Yan-wen;FANG Xiao-ling
出处 《护理实践与研究》 2018年第20期109-110,共2页 Nursing Practice and Research
关键词 延续性护理 乳腺癌晚期 生存期 生活质量 Continuous Nursing Advanced breast cancer Survival Quality of life
  • 相关文献

参考文献8

二级参考文献79

  • 1胡雁,Ken Sellick.癌症康复评价系统简表中文版的信度和效度[J].中国心理卫生杂志,2006,20(2):76-80. 被引量:51
  • 2张国华,许明智,金海燕.医院焦虑抑郁量表的因素结构研究[J].中国临床心理学杂志,2006,14(6):591-592. 被引量:30
  • 3Fan L,Strasser-Weippl K,Li JJ,et al. Breast cancer in China[J/ CD]. Lancet Oncol,2014,15 (7):e279-289.
  • 4Sack T,Takashima S, Sano M,et al. A phase ii study of s-1 in patients with metastatic breast cancer a japanese trial by the s 1 cooperative study group, breast cancer working group [J]. Breast Cancer, 2004,11 (2) :194-202.
  • 5Yamamoto D,Iwase S,Tsubota Y,et al. Randomized study of o- rally administered fluorinated pyrimidines (capecitabine versusS 1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial [J]. Cancer Chemoth er Pharmacol, 2015,75(6) : 1183-1189.
  • 6Therasse P, Arbuck SG,Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the UnitedStates, National Cancer Institute of Canada[J]. J Natl Cancer Inst,2000,92(3) :205-216.
  • 7Chen AP, Setser A,Anadkat MJ,et al. Grading dermatologic ad- verse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0[J]. J Am Acad Derma- tol,2012,67(5) :1025-1039.
  • 8Dear RF,McGeechan K, Jenkins MC, et al. Combination versus sequential single agent chemotherapy for metastatic breast cancer [J]. Cochrane Database Syst Rev, 2013,12 : CD008792.
  • 9Hong JY,Park YH,Choi MK,et al. Characterization of durable responder for capecitabine monotherapy in patients with anthra- cycline- and taxane-pretreated metastatic breast cancer[J/CD]. Clin Breast Cancer,2015,15(5) :e287-292.
  • 10Sanford M. S-1 (Teysuno) : A review of its use in advanced gastric cancer in non-asian populations[J]. Drugs, 2013,73 (8) : 845-855.

共引文献249

同被引文献99

引证文献12

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部